Loss of Siglec expression on T lymphocytes during human evolution
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
We report here that human T cells give much stronger proliferative responses to specific activation via the T cell receptor (TCR) than those from chimpanzees, our closest evolutionary relatives. Nonspecific activation using phytohemagglutinin was robust in chimpanzee T cells, indicating that the much lower response to TCR simulation is not due to any intrinsic inability to respond to an activating stimulus. CD33-related Siglecs are inhibitory signaling molecules expressed on most immune cells and are thought to down-regulate cellular activation pathways via cytosolic immunoreceptor tyrosine-based inhibitory motifs. Among human immune cells, T lymphocytes are a striking exception, expressing little to none of these molecules. In stark contrast, we find that T lymphocytes from chimpanzees as well as the other closely related “great apes” (bonobos, gorillas, and orangutans) express several CD33-related Siglecs on their surfaces. Thus, human-specific loss of T cell Siglec expression occurred after our last common ancestor with great apes, potentially resulting in an evolutionary difference with regard to inhibitory signaling. We confirmed this by studying Siglec-5, which is prominently expressed on chimpanzee lymphocytes, including CD4 T cells. Ab-mediated clearance of Siglec-5 from chimpanzee T cells enhanced TCR-mediated activation. Conversely, primary human T cells and Jurkat cells transfected with Siglec-5 become less responsive; i.e., they behave more like chimpanzee T cells. This human-specific loss of T cell Siglec expression associated with T cell hyperactivity may help explain the strikingly disparate prevalence and severity of T cell-mediated diseases such as AIDS and chronic active hepatitis between humans and chimpanzees.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, a recent study showed that chimpanzee T cells are also less responsive towards in vitro stimulation than human T cells and it was suggested that this might be due to loss of Siglec expression on human T cells [45].”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [45]
In the citing paper
“Siglecs are inhibitory receptors that are related to CD33 and it appears as if their expression is lost on T cells during evolution from monkey to human [45].”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [45]
In the citing paper
“human T cells express little to none of the CD33-related siglecs, which are inhibitory signaling molecules on the cell surface that downregulate cellular activation pathways (12).”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [12]
In the citing paper
“In contrast, chimpanzees and monkeys express abundant levels of CD33-related siglecs on the surface of their T cells, which also show lower amounts of T cell proliferation and activation than their human counterparts upon stimulation with anti-CD3 and antiCD28 antibodies.”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [12]
Citations
Cites
Initial sequence of the chimpanzee genome and comparison with the human genome
The Chimpanzee Sequencing and Analysis Consortium (2005) · Nature · doi:10.1038/nature04072 · Cited by 2,459
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
Wood, B., & Collard, M. (1999) · Science · doi:10.1126/science.284.5411.65 · Cited by 714
Siglecs—the major subfamily of I-type lectins
Varki, A., & Angata, T. (2006) · Glycobiology · doi:10.1093/glycob/cwj008 · Cited by 518
Self-citationSiglecs, sialic acids and innate immunity
Crocker, P. R., & Varki, A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01930-5 · Cited by 382
Self-citationMitochondrial sequences show diverse evolutionary histories of African hominoids
Gagneux, P., Wills, C., Gerloff, U., Tautz, D., Morin, P. A., Boesch, C., Fruth, B., Hohmann, G., Ryder, O. A., & Woodruff, D. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5077 · Cited by 350
Self-citationComparing the human and chimpanzee genomes: Searching for needles in a haystack
Varki, A., & Altheide, T. K. (2005) · Genome Research · doi:10.1101/gr.3737405 · Cited by 344
Self-citationVarki, A. (2001) · American Journal of Physical Anthropology · doi:10.1002/ajpa.10018 · Cited by 324
Self-citationTransmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDS
Alter, H. J., Eichberg, J. W., Masur, H., Saxinger, W. C., Gallo, R., Macher, A. M., Lane, H. C., & Fauci, A. S. (1984) · Science · doi:10.1126/science.6093251 · Cited by 319
Research works printed but not linked: 1
- P. Gagneux, E. A. Muchmore Methods Mol. Med 96, 289–318 (2004).
Cited by
Items 101–200 of 208
Haas, Q., Markov, N., Muerner, L., Rubino, V., Benjak, A., Haubitz, M., Baerlocher, G. M., Ng, C. K. Y., Münz, C., Riether, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.996746 · Cited by 39
Ploquin, M. J.-Y., Desoutter, J.-F., dos Santos, P. R., Pandrea, I., Diop, O. M., Hosmalin, A., Butor, C., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2006) · Retrovirology · doi:10.1186/1742-4690-3-37 · Cited by 44
“the level of Nef-mediated downregulation of CD3 [39] or the levels of Siglec expression [40], for the levels of T cell activation and thus for the outcome of HIV/ SIV infections.”
BackgroundThe role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells
Kumar, N., Cheong, K., Powell, D., Pereira, C. D. F., Anderson, J. L., Evans, V. A., Lewin, S. R., & Cameron, P. U. (2015) · Retrovirology · doi:10.1186/s12977-015-0204-2 · Cited by 39
“SIGLEC 5 has been shown to inhibit T-cell activation in chimpanzees, where blockade of SIGLEC 5 led to increased T-cell activation, and transfection of SIGLEC 5 into SIGLEC negative cells reduced T-cell activation [64–67].”
BackgroundCell Death Modulation by Intravenous Immunoglobulin
von Gunten, S., & Simon, H. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9411-8 · Cited by 38
“Whereas some Siglec members are evolutionary conserved in mammalians, the remaining members, especially those of the CD33-related subgroup, which includes Siglec-8 and Siglec-9, differ in structure or expression levels depending on the species [27–29, 31].”
BackgroundSiglec-10 expression is up-regulated in activated human CD4+ T cells
Bandala‐Sanchez, E., Bediaga, N. G., Naselli, G., Neale, A. M., & Harrison, L. C. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.01.009 · Cited by 35
Saini, P., Adeniji, O. S., & Abdel‐Mohsen, M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104354 · Cited by 33
Kim, N., Dabrowska, A., Jenner, R. G., & Aldovini, A. (2007) · Journal of Virology · doi:10.1128/jvi.02616-06 · Cited by 32
“CD28, which does not work well in this species (37).”
BackgroundKojima, M., Suzuki, K., Takeshita, M., Ohyagi, M., Iizuka, M., Yamane, H., Koga, K., Kouro, T., Kassai, Y., Yoshihara, T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04874-3 · Cited by 32
Rutjens, E., Mazza, S., Biassoni, R., Koopman, G., Radic, L., Fogli, M., Costa, P., Mingari, M. C., Moretta, L., Heeney, J. L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1702 · Cited by 31
From mechanism to therapy: the journey of CD24 in cancer
Zhao, K., Wu, C., Li, X., Niu, M., Wu, D., Cui, X., & Hai, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401528 · Cited by 33
“CD22 is one of Siglec (sialic acid-binding immunoglobulin-type lectin) that primarily functions as an immune checkpoint on B cells (89).”
BackgroundMicroglial carbohydrate-binding receptors for neural repair
Linnartz‐Gerlach, B., Bodea, L., & Neumann, H. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1342-7 · Cited by 32
“…are involved in many inhibitory processes such as the induction of cell death (Nutku et al. 2003; von Gunten et al. 2005), the suppression of cellular activities (Paul et al. 2000), antiproliferative effects (Nguyen et al. 2006), endocytosis and cell-cell interaction processes (Lock et al. 2004).”
BackgroundNordström, T., Movert, E., Olin, A. I., Ali, S. R., Nizet, V., Varki, A. P., & Areschoug, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.251728 · Cited by 30
Self-citationCell resilience in species life spans: a link to inflammation?
Finch, C. E., Morgan, T. E., Longo, V. D., & De Magalhaes, J. P. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00578.x · Cited by 29
“chimpanzee CD4 T cells, as shown by expression manipulation (Nguyen et al., 2006).”
BackgroundPoirier, N., Mary, C., Bas‐Bernardet, S. L., Daguin, V., Belarif, L., Chevalier, M., Hervouet, J., Minault, D., Ville, S., Charpy, V., et al. (2014) · mAbs · doi:10.4161/mabs.28375 · Cited by 28
Schindler, M., Wildum, S., Casartelli, N., Doria, M., & Kirchhoff, F. (2007) · AIDS · doi:10.1097/qad.0b013e32816aa37c · Cited by 27
“Moreover, it has been proposed that the low responsiveness of chimpanzee T cells to activation might explain why HIV-1 and SIVcpz infection usually does not cause disease in this primate species [26,27].”
BackgroundWalker, M., Makropoulos, D., Achuthanandam, R., Arsdell, S. V., & Bugelski, P. J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.06.001 · Cited by 27
“Differences in expression of target molecules, avidity of binding, regulatory T cell expression, cytokines required for inflammatory responses, and expression of siglecs among humans, rodents, and non-human primates may all contribute to the inability of animals to predict CRS [6–12].”
BackgroundKarmakar, J., Mukherjee, K., & Mandal, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758588 · Cited by 27
The mammalian complement system as an epitome of host–pathogen genetic conflicts
Cagliani, R., Forni, D., Filippi, G., Mozzi, A., GIOIA, L. D., Pontremoli, C., Pozzoli, U., Bresolin, N., Clerici, M., & Sironi, M. (2016) · Molecular Ecology · doi:10.1111/mec.13558 · Cited by 26
“Unique among hominids, for instance, human T cells express little or no regulatory SIGLECs (sialic acid-recognizing Ig-superfamily lectins), resulting in more vigorous activation (Nguyen et al. 2006).”
BackgroundGenomic Comparisons of Humans and Chimpanzees
Varki, A. P., & Nelson, D. L. (2007) · Annual Review of Anthropology · doi:10.1146/annurev.anthro.36.081406.094339 · Cited by 26
“This loss of negative signaling may account for the hyperreactivity of human T cells (Nguyen et al. 2006).”
BackgroundSelf-citationDanilenko, D. M., & Wang, H. (2012) · Toxicologic Pathology · doi:10.1177/0192623311430237 · Cited by 24
“2008), and hyperresponsiveness of human T cells to polyclonal activation caused by the lack of the CD33-related siglec inhibitory signaling molecule that is present in nonhuman primates (Nguyen et al. 2006).”
BackgroundKessler, S. E., Bonnell, T. R., Setchell, J. M., & Chapman, C. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-31568-2 · Cited by 25
Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec‐7
Fan, T., Liao, Q., Zhao, Y., Dai, H., Song, S., He, T., Wang, Z., Huang, J., Zeng, Z., Guo, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15631 · Cited by 23
May, L. T., Bartolo, B. A. D., Harrison, D. G., Guzik, T. J., Drummond, G. R., Figtree, G. A., Ritchie, R. H., Rye, K., & de Haan, J. B. (2022) · Clinical Science · doi:10.1042/cs20210862 · Cited by 24
Montag, T., Spreitzer, I., Löschner, B., Unkelbach, U., Flory, E., Sanzenbacher, R., Schwanig, M., & Schneider, C. K. (2007) · ALTEX · doi:10.14573/altex.2007.2.81 · Cited by 28
“Further, the immune system of animals has evolved significantly over evolution to Homo sapiens sapiens, and there are reports that the human immune system might be more susceptible to T cell activation than even that of chimpanzees (Nguyen et al., 2006).”
BackgroundBrennan, F. R., Cauvin, A. J., Tibbitts, J., & Wolfreys, A. (2014) · Drug Development Research · doi:10.1002/ddr.21173 · Cited by 23
“Compared with chimpanzee and macaque T cells, human T cells exhibit stronger proliferative responses upon activation via the T cell receptor, a response that is attributed to the loss of T cell siglec (Sialic acid-binding immunoglobulin-type lectin) expression from human T cells [Nguyen et al., 2006].”
BackgroundEnhanced T Cell Function in a Mouse Model of Human Glycosylation
Buchlis, G., Odorizzi, P. M., Soto, P. C., Pearce, O. M. T., Hui, D. J., Jordan, M. S., Varki, A. P., Wherry, E. J., & High, K. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202905 · Cited by 24
“These results are similar to studies done in human versus chimpanzee T cells, where human T cells proliferate more than equivalently stimulated chimpanzee T cells (19, 20).”
BackgroundResultSelf-citationPleticha, J., Heilmann, L. F., Evans, C. H., Asokan, A., Samulski, R. J., & Beutler, A. S. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-54 · Cited by 21
“A comparison of rodents, large animal species, and humans showed that humans are prone to mount a cellular immune response to systemic AAV more readily than other species [46,47].”
BackgroundTranslating pharmacology models effectively to predict therapeutic benefit
Dudal, S., Bissantz, C., Caruso, A., David‐Pierson, P., Driessen, W. H. P., Koller, E., Krippendorff, B., Lechmann, M., Olivares‐Morales, A., Paehler, A., et al. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.03.009 · Cited by 22
Jaroenpool, J., Rogers, K. A., Pattanapanyasat, K., Villinger, F. J., Onlamoon, N., Crocker, P. R., & Ansari, A. A. (2007) · Cellular Immunology · doi:10.1016/j.cellimm.2008.01.009 · Cited by 20
“Thus, as described above, humans appeared to have lost the expression of Siglec-5 on T cells [6] as compared with chimpanzees that readily express Siglec-5 on lymphoid cells which was shown to account for their decreased levels of proliferation following TCR ligation.”
BackgroundInfluentialSurrogate approaches in development of monoclonal antibodies
Bornstein, G. G., Klakamp, S. L., Andrews, L., Boyle, W. J., & Tabrizi, M. A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.014 · Cited by 21
Khan, N., de Manuel, M., Peyrégne, S., Do, R., Prüfer, K., Marquès‐Bonet, T., Varki, N. M., Gagneux, P., & Varki, A. P. (2020) · Genome Biology and Evolution · doi:10.1093/gbe/evaa125 · Cited by 21
Self-citationPresentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans
Izzati, F. N., Choksi, H., Giuliana, P., Abd-Rabbo, D., Elsaesser, H. J., Blundell, A., Affe, V., Kannen, V., Jame-Chenarboo, Z., Schmidt, E. N., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115933 · Cited by 17
Soto, P. C., Karris, M., Spina, C. A., Richman, D. D., & Varki, A. P. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0951-7 · Cited by 16
“One host difference between human and chimpanzee CD4+ T cells is much higher expression of inhibitory Siglecs (sialic acid-binding immunoglobulin-like lectins) in the latter [9].”
BackgroundSelf-citationEisenberg, V., Hoogi, S., Katzman, E., Haim, N. B., Zur-Toledano, R., Radman, M., Reboh, Y., Zadok, O., Kamer, I., Bar, J., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0823 · Cited by 15
Bozzano, F. M., Nasi, M., Bertoncelli, L., Nemes, E., Prati, F., Marras, F., Mussini, C., Moretta, L., Cossarizza, A., & Maria, A. D. (2011) · International Immunology · doi:10.1093/intimm/dxq462 · Cited by 14
“mechanisms that dampen HIV-specific responses (39, 40).”
Vaill, M., Kawanishi, K., Varki, N. M., Gagneux, P., & Varki, A. P. (2023) · Physiological Reviews · doi:10.1152/physrev.00040.2021 · Cited by 14
Self-citationThe effect of CD33 expression on inflammatory response in chronic obstructive pulmonary disease
Zhang, L.-X., Ye, J., Chen, Y.-B., Peng, H., Chen, X., Liu, L., Jiang, A.-G., & Huang, J. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.806542 · Cited by 13
Lin, F.-K., Pan, C.-L., Yang, J., Chuang, T., & Chen, F. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-164 · Cited by 13
Evolution of the Human Immune System
Danilova, N. (2008) · Wiley eBooks · doi:10.1002/9780470015902.a0020781 · Cited by 17
Ben‐Arye, S. L., Schmidt, E. N., Jame-Chenarboo, Z., Guetta-Oz, C., Mozaneh, F., Jung, J., McCord, K. A., Rosenfeld, R., Zhong, K., Cao, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71086-8 · Cited by 13
“Despite this accumulated knowledge, there are inconsistent reports of Siglec expression patterns, complicated by the fact that each immune cell type expresses several Siglecs 10,21 .”
Expression and Function of Siglec-8 in Human Eosinophils, Basophils, and Mast Cells
von Gunten, S., & Bochner, B. S. (2009) · Springer eBooks · doi:10.1007/978-4-431-88315-9_19 · Cited by 12
“The Siglecs seem to have tailored their binding properties to the evolutionary changes that occurred in their sialic acid-containing ligands [9, 44].”
BackgroundSystematic review of chimpanzee use in monoclonal antibody research and drug development: 1981-2010
Bettauer, R. H. (2011) · ALTEX · doi:10.14573/altex.2011.2.103 · Cited by 12
“Among other carbohydrates, these molecules have important functions in protein conformation and solubility and effector immune responses (Nguyen, 2006).”
Human-like Response of Pig T Cells to Superagonistic Anti-CD28 Monoclonal Antibodies
Uehlein, S., Ding, X., Flößer, J., Schmidt, S., Steitz, J., Bille, M., Schnitter, F., Baltes, S., Saalmüller, A., Gerner, W., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100174 · Cited by 15
Varicella Zoster Virus infects mucosal associated Invariant T cells
Purohit, S. K., Corbett, A. J., Slobedman, B., & Abendroth, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1121714 · Cited by 12
Gene Expression Profiling in Pediatric Appendicitis
Dhillon, B. K., Kortbeek, S., Baghela, A. S., Brindle, M. E., Martin, D.-A., Jenne, C. N., Vogel, H. J., Lee, A. H., Thompson, G. C., & Hancock, R. E. W. (2024) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2023.6721 · Cited by 11
Decker, J. M., Zammit, K. P., Easlick, J. L., Santiago, M. L., Bonenberger, D., Hahn, B. H., Kutsch, O., & Bibollet‐Ruche, F. (2009) · Virology · doi:10.1016/j.virol.2009.08.027 · Cited by 12
“A more recent study noted differences in the proliferative response between human and chimpanzee T-cells (Nguyen et al., 2006).”
BackgroundMethodInfluentialEvolution of the Human Immune System
Danilova, N. (2015) · Wiley eBooks · doi:10.1002/9780470015902.a0020781.pub2 · Cited by 10
“Siglec-5 and several other Siglecs are expressed in great apes but not human lymphocytes (Nguyen et al., 2006).”
BackgroundA Novel Function of Siglec-9 A391C Polymorphism on T Cell Receptor Signaling
Cheong, K. A., Chang, Y., Roh, J. Y., Kim, B.-J., Kim, M.-N., Park, Y. M., Park, H., Kim, N. D., Lee, C., & Lee, A. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000320225 · Cited by 8
Sialic acid and food allergies: The link between nutrition and immunology
Liu, G., Hao, M., Zeng, B., Liu, M., Wang, J., Sun, S., Liu, C., & HuiLian, C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2136620 · Cited by 9
“Nguyen et al. (2006) found that humans have low Siglecs expression levels on resting T cells compared with levels in other closely related primates.”
BackgroundAnalysis of cytokine release assay data using machine learning approaches
Xiong, F., Janko, M., Walker, M., Makropoulos, D., Weinstock, D., Kam, M., & Hrebien, L. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.024 · Cited by 9
Bacillus Subtilis–Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in Vitiligo
Touni, A. A., Muttar, S., Siddiqui, Z., Shivde, R. S., Krischke, E., Paul, D., Youssef, M. A., Sperling, A. I., Abdel-Aziz, R. T. A., Abdel‐Wahab, H., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.12.006 · Cited by 8
Consequences and Indicators of Test Article-Related Immune Suppression in Nonhuman Primates
Shenton, J. M., Henson, K. L., & Rebelatto, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417144-2.00011-1 · Cited by 8
Evans, E. W. (2013) · Toxicologic Pathology · doi:10.1177/0192623313513075 · Cited by 7
“…of the CD28 agonist TGN1412; current hypotheses suggest that monkey T cells may have inhibitory mechanisms not present in humans or that the effector cells are CD28þ in humans but CD28 in monkeys (Brennan et al. 2010; Pallardy and Hunig 2010; Nguyen et al. 2006; Eastwood et al. 2010).”
BackgroundIwata, Y., Harada, A., Hara, T., Kubo, C., Inoue, T., Tabo, M., Ploix, C. C., Manigold, T., Hinton, H. J., & Mishima, M. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.523 · Cited by 7
“Differences were reported in the expression of the target molecule on memory T cells (Eastwood et al., 2010), Ca2+-signal strength (Waibler et al., 2008), inhibitory Siglec-5 molecules (Nguyen et al., 2006), FcγR expression patterns, and binding affinities (Warncke et al., 2012).”
BackgroundBibollet‐Ruche, F., McKinney, B. A., Duverger, A. E., Wagner, F. H., Ansari, A. A., & Kutsch, O. (2008) · Journal of Virology · doi:10.1128/jvi.01319-08 · Cited by 7
“In any case, whether Siglecs truly play a role in restricting chimpanzee T-cell activation and as a result in SIV pathogenesis would have to be reevaluated (16).”
BackgroundInfluentialKumar, A. A.-W., Huangfu, G., Figtree, G. A., & Dwivedi, G. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00744.2023 · Cited by 7
Human susceptibility to coronary artery disease: lessons from chimpanzee resilience
Figtree, G. A., Kovacic, J. C., & McGuire, H. M. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00738-1 · Cited by 6
Psychoneuroimmunology in the Daily Clinic is Only Possible Within a Contextual Frame
Pruimboom, L., Rocio, F. A., & Ledesma, S. N. (2024) · Integrated science · doi:10.1007/978-3-031-73061-0_16 · Cited by 7
First-in-human trials with therapeutic proteins: regulatory rethink?
Schneider, C. K. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.3.327 · Cited by 6
Liu, T., Wu, G., Gudd, C. L. C., Trovato, F. M., Barbera, T. A., Liu, Y., Triantafyllou, E., McPhail, M. J. W., Thursz, M. R., & Khamri, W. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105336 · Cited by 5
“42,43 Our fi ndings indicate that typically low Siglec-10 expression levels were elevated in CD4 + T cells in AD, mirroring the trend observed with CD52.”
Human-Specific Changes in Sialic Acid Biology
Hayakawa, T., & Varki, A. P. (2011) · Primatology monographs · doi:10.1007/978-4-431-54011-3_8 · Cited by 6
“Although the majority of chimpanzee CD4+ T cells express Siglec-5 and/or Siglec-14, CD4+ T cells in humans are mostly negative (Nguyen et al.”
BackgroundSelf-citationTranslational immunotoxicology of immunomodulatory monoclonal antibodies
Brennan, F. R., & Kießling, A. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.08.002 · Cited by 5
“chimpanzee T cells, human T cells exhibit stronger proliferative responses upon activation via the T cell receptor, due to the loss of inhibitory members of the Siglec family on human T cells [18].”
BackgroundPosttranslational sialylation and its impact on neutrophil recruitment
Nussbaumer, K., Marth, J. D., & Sperandio, M. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf113 · Cited by 4
“73 Siglecs can recognize various Sia linkages, but each Siglec shows a degree of specificity for different substrates.”
Mantuano, N. R., Bärenwaldt, A., Sarcevic, M., Siqueira, I. V. M., Jauch, A., Etter, M. M., Matter, M. S., Hütter, G., Recher, M., & Laubli, H. P. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf340 · Cited by 4
“In general, Siglec receptors are at lower level expressed in humans than in other mammals (17, 18).”
Mahim, A., & Petering, D. H. (2022) · Metallomics · doi:10.1093/mtomcs/mfac081 · Cited by 4
Visich, J. E., & Ponce, R. A. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse199 · Cited by 4
Ponce, R. A. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2011.603390 · Cited by 3
“The basis for this interspecies difference remains unresolved, but may be attributed to an evolutionary divergence in T-cell regulation (Nguyen et al., 2006; Soto et al., 2010; Eastwood et al.).”
BackgroundUncloaking the viral glycocalyx: How do viruses exploit glycoimmune checkpoints?
Domma, A. J., Henderson, L. A., Nurdin, J. A., & Kamil, J. P. (2024) · Advances in virus research · doi:10.1016/bs.aivir.2024.03.001 · Cited by 3
Kwak, C.-H., Song, K., Kim, H.-D., Park, J., & Kim, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115535 · Cited by 3
Pulmonary Immunology of Infectious Disease
Burleson, G. R., Burleson, S. C. M., & BURLESON, F. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-404577-4.00030-8 · Cited by 4
The Selfish Immune System when the Immune System Overrides the ‘Selfish’ Brain
Pruimboom, L. (2020) · Journal of Immunology and Clinical Microbiology · Cited by 6
Rutjens, E., Vermeulen, J. N., Verstrepen, B. E., Hofman, S., Prins, J. M., Srivastava, I. K., Heeney, J. L., & Koopman, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200737792 · Cited by 3
Diagnostic significance of salivary and glandular siglec-5 in Sjögren disease and non-Sjögren sicca
Castro, F. L. A. D. L., Nunes, L. F. M., Felix, F. A., Oliveira, S. D., de Arruda, J. A. A., Drumond, V. Z., Abreu, L. G., Rocha, A. C. H., Lara, C. M., dos Santos, H. T., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02188-8 · Cited by 2
“Although earlier studies suggested limited expression in T cells [28], more recent evidence indicates that acti - vated T cells can express siglec-5 through post-translational mechanisms [ 11 ].”
Risiken und Nebenwirkungen von Arzneimitteln
Otte, A., Siskou, M., Lieber, D., Barsch, M., Konur, A., & Matzke, O. (2009) · Cited by 2
Hawash, M. B. F., Eldeeb, M. A., Gaber, R., & Morsy, K. (2022) · BioEssays · doi:10.1002/bies.202200080 · Cited by 2
“[93] Remarkably, T cells from the closely related species, chimpanzee, were found to express CD33-related siglecs.[34] Nguyen and colleagues studied the expression of siglec-5 in T cells from human and chimpanzee and found a significantly higher proliferation of human T cells (2 fold) upon activation by immobilized an…”
BackgroundInfluentialEstimation of Human Starting Dose for Phase I Clinical Programs
Buckley, L. A., Garhyan, P., Ponce, R. A., & Roberts, S. (2010) · Wiley eBooks · doi:10.1002/9780470613191.ch10 · Cited by 2
Dunn, R. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-41088-3_5 · Cited by 2
Bernton, E. W. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse173 · Cited by 2
Cameron, D. B. (2009) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.234.1.39 · Cited by 2
Rakib, A., Mamun, M. A. A., Mandal, M., Yasmen, N., Ofosu-Boateng, M., Collier, D. M., Park, F., Gyamfi, M. A., Jiang, J., & Singh, U. P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115952 · Cited by 1
CD33 (Siglec 3) and CD33-Related Siglecs
Gupta, A. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_17 · Cited by 1
Ajit Varki: On the origin of maladies
Maxmen, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.2069pi · Cited by 1
Novel Neutrophil Receptors and Their Signal Transduction
Fortenbery, N. R., Chen, X., & Wei, S. (2013) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848168374_0003 · Cited by 1
Fleming, R. M. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.10.002006 · Cited by 1
Immunotoxicology of Biopharmaceutics
Haggerty, H. G., Price, K. D., & Shenton, J. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100601-6.02008-1 · Cited by 1
Sialic acids in autoimmune disorders
Ghosh, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816126-5.00006-8 · Cited by 1
Mu, Y., Godar, D. E., & Merrill, S. J. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0137 · Cited by 1
Immunotoxicology of Biopharmaceutics
Haggerty, H. G., Price, K., & Shenton, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00629-1
Characterization of the biophysical and cellular aspects of pertussis toxin binding
Millen, S. H. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Trivedi, P. J. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
[Cellular immunotoxicity of rAAV gene medicine and possible solutions].
Diao, Y., Qizhao, W., Xiao, W., & Xu, R. (2010) · PubMed
Agyeman, A. A. (2016) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2016.04.00103
Batista, L. F. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2016.tde-10062016-150220 · Cited by 2
Rm, F., Harrington, G. M., Ayoob, K. T., Grotto, D. W., Tk, C., & McKusick, A. (2018) · Archives of Medicine · doi:10.21767/1989-5216.1000284 · Cited by 1
“From a practical perspective the procedures employed here work well for both weight reduction/control and maintaining/improving cardiovascular health through the reduction of the inflammatory process seen in humans in contrast to other primates and other animals [57,58].”
MethodAl Zamil, M. (2018) · Open Access Journal of Translational Medicine & Research · doi:10.15406/oajtmr.2018.02.00051
Genetic Footprints of Natural Selection and Drift in Human Evolution
Somel, M., & Sezgın, E. (2010) · Hacettepe Journal of Biology and Chemistry
(2014) · ASM Press eBooks · doi:10.1128/9781555815653.refs
Immunotoxicology of Biopharmaceutics☆
Haggerty, H. G., Price, K., & Shenton, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02008-0
Gagneux, P. (2017) · Wiley eBooks · doi:10.1002/9781119179313.wbprim0270
Self-citationThe hematolymphoid system of the non-human primate
Chamanza, R., Naylor, S. W., & Chilton, J. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-813088-9.00022-7
Metadata
- Authors
- Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P., & Varki, A.
- Affiliations
- University of California San Diego (US)
- *Glycobiology Research and Training Center and Departments of Medicine and Cellular and Molecular Medicine, and
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-05-16
- Volume
- 103
- Issue
- 20
- Pages
- 7765-7770
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2142499414
- Cited by
- 204
- References
- 39
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 12 · 2021: 7 · 2020: 6 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 11 · 2015: 7 · 2014: 11 · 2013: 10 · 2012: 12
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health (GM32373)
- Yerkes National Primate Research Center, Emory University
- National Heart, Lung, and Blood Institute (P01HL057345)
- National Institute of General Medical Sciences (R01GM032373, R01-GM-32373)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Siglecs, Siglec-5, T cells, chimpanzees, great apes, human evolution, T cell receptor signaling, inhibitory signaling, T cell proliferation, AIDS, chronic active hepatitis, ITIM
- MeSH terms
- Animals, B-Lymphocytes, Calcium, Pan troglodytes, Biological Evolution, Humans, Lymphocyte Activation, Receptors, Antigen, T-Cell, Sialic Acids, T-Lymphocytes, Antigens, Differentiation, Myelomonocytic, Down-Regulation, Antigens, CD, Lectins, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.